山东大学耳鼻喉眼学报 ›› 2023, Vol. 37 ›› Issue (3): 93-97.doi: 10.6040/j.issn.1673-3770.0.2022.044
• 论著 • 上一篇
张懿,唐莉
ZHANG Yi, TANG Li
摘要: Lowe综合征为罕见的X连锁隐形遗传病,诊断主要依赖于临床表现及基因检测。本例患儿于白内障术后随访发现眼压升高,进而诊断为双眼青光眼并进行了手术治疗,提示Lowe综合征患者各种临床表现可随成长逐渐显露,需长期随访,密切关注,及时干预。本例患儿发生了OCRL第22号外显子移码突变,该突变位点目前国内尚无文献报道,进一步丰富Lowe综合征的基因谱。
中图分类号:
[1] Lowe CU, Terrey M, MacLachlan EA. Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity[J]. AMA Am J Dis Child, 1952, 83(2): 164-184. doi:10.1001/archpedi.1952.02040060030004 [2] 高珊,李晶晶,林俊.儿童Lowe综合征2例报告[J].四川大学学报(医学版),2019,50(1):144. doi:10.13464/j.scuxbyxb.2019.01.035 [3] 张晓滢,孙良忠,刘婷,等. 六个Lowe综合征家系七例患儿的临床特征与OCRL1基因突变[J].中华肾脏病杂志, 2020, 36(5):372-378. doi:10.3760/cma.j.cn441217-20191115-00071 ZHANG Xiaoying, SUN Liangzhong, LIU Ting, et al. Clinical features of Lowe syndrome and OCRL1 mutations in seven cases from six families[J]. Chin J Nephrol, 2020, 36(5): 372-378. doi:10.3760/cma.j.cn441217-20191115-00071 [4] Lin T, Orrison BM, Leahey AM, et al. Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome[J]. Am J Hum Genet, 1997, 60(6): 1384-1388. doi:10.1086/515471 [5] 张永玲, 李茹, 景象一, 等. 一例Lowe综合征患儿的临床及分子遗传学诊断[J]. 中华医学遗传学杂志, 2019, 36(6): 613-615. doi:10.3760/cma.j.issn.1003-9406.2019.06.021 ZHANG Yongling, LI Ru, JING Xiangyi, et al. Clinical and molecular genetic analysis of a pediatric patient with Lowe syndrome[J]. Chinese Journal of Medical Genetics, 2019, 36(6): 613-615. doi:10.3760/cma.j.issn.1003-9406.2019.06.021 [6] 白周现, 刘莉娜, 胡爽, 等. 一例OCRL基因外显子重复变异所致的眼脑肾综合征患儿的临床及遗传学分析[J]. 中华医学遗传学杂志, 2020, 37(1): 28-32. doi:10.3760/cma.j.issn.1003-9406.2020.01.008 BAI Zhouxian, LIU Lina, HU Shuang, et al. Clinical and genetic analysis of an infant with Lowe syndrome caused by exonic duplication of OCRL gene[J]. Chinese Journal of Medical Genetics, 2020, 37(1): 28-32. doi:10.3760/cma.j.issn.1003-9406.2020.01.008 [7] Tatsi P, Papanikolaou GE, Chartomatsidou T, et al. Lowe syndrome identified in the offspring of an oocyte donor who was an unknown carrier of a de novo mutation: a case report and review of the literature[J]. J Med Case Rep, 2019, 13(1): 325. doi:10.1186/s13256-019-2263-9 [8] Zhou FQ, Wang QW, Liu ZZ, et al. Novel mutation in OCRL leading to a severe form of Lowe syndrome[J]. Int J Ophthalmol, 2019, 12(7): 1057-1060. doi:10.18240/ijo.2019.07.01 [9] Bökenkamp A, Ludwig M. The oculocerebrorenal syndrome of Lowe: an update[J]. Pediatr Nephrol, 2016, 31(12): 2201-2212. doi:10.1007/s00467-016-3343-3 [10] Sun J, Zhou Z, Weng C, et al. Identification and functional characterization of a hemizygous novel intronic variant in OCRL gene causes Lowe syndrome[J]. Clin Exp Nephrol, 2020, 24(8): 657-665. doi:10.1007/s10157-020-01897-6 [11] Ramadesikan S, Skiba L, Lee J, et al. Genotype & phenotype in Lowe Syndrome: specific OCRL1 patient mutations differentially impact cellular phenotypes[J]. Hum Mol Genet, 2021, 30(3/4): 198-212. doi:10.1093/hmg/ddab025 [12] Ramos AR, Ghosh S, Erneux C. The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease[J]. J Lipid Res, 2019, 60(2): 276-286. doi:10.1194/jlr.r087908 [13] Madhivanan K, Ramadesikan S, Hsieh WC, et al. Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins[J]. Hum Mol Genet, 2020, 29(10): 1700-1715. doi:10.1093/hmg/ddaa086 [14] Dumic KK, Anticevic D, Petrinovic-Doresic J, et al. Lowe syndrome-Old and new evidence of secondary mitochondrial dysfunction[J]. Eur J Med Genet, 2020, 63(10): 104022. doi:10.1016/j.ejmg.2020.104022 [15] Mehta ZB, Pietka G, Lowe M. The cellular and physiological functions of the Lowe syndrome protein OCRL1[J]. Traffic, 2014, 15(5): 471-487. doi:10.1111/tra.12160 [16] Daskalakis G, Anastasakis E, Lyberopoulos E, et al. Prenatal detection of congenital cataract in a fetus with Lowe syndrome[J]. J Obstet Gynaecol, 2010, 30(4): 409-410. doi:10.3109/01443611003698695 [17] 谭健文, 赖一凡. Lowe综合征的眼部表现及其诊治[J]. 国际眼科纵览, 2014, 38(5): 330-333. doi:10.3760/cma.j.issn.1673-5803.2014.05.009 TAN Jianwen, LAI Yifan. Ocular manifestation and treatment in Lowe syndrome[J]. International Review of Ophthalmology, 2014, 38(5): 330-333. doi:10.3760/cma.j.issn.1673-5803.2014.05.009 [18] 周新龙, 王清明, 邹姒妮, 等. 一个眼-脑-肾综合征家系的 OCRL基因变异研究[J]. 中华医学遗传学杂志, 2022, 39(1): 56-59. doi:10.3760/cma.j.cn511374-20200617-00448 ZHOU Xinlong, WANG Qingming, ZOU Sini, et al. Analysis of OCRL gene variant in a Chinese pedigree affected with Lowe syndrome[J]. Chinese Journal of Medical Genetics, 2022, 39(1): 56-59. doi:10.3760/cma.j.cn511374-20200617-00448 [19] Ma X, Ning K, Jabbehdari S, et al. Oculocerebrorenal syndrome of Lowe: survey of ophthalmic presentations and management[J]. Eur J Ophthalmol, 2020, 30(5): 966-973. doi:10.1177/1120672120920544 [20] Walton DS, Katsavounidou G, Lowe CU. Glaucoma with the oculocerebrorenal syndrome of lowe[J]. J Glaucoma, 2005, 14(3): 181-185. doi:10.1097/01.ijg.0000158850.07732.05 [21] 张辉, 谢立信. 婴幼儿先天性白内障术后继发性青光眼的临床分析[J]. 中华眼科杂志, 2013, 49(2): 134-138. doi:10.3760/cma.j.issn.0412-4081.2013.02.009 ZHANG Hui, XIE Lixin. Clinical analysis of the occurrence of secondary glaucoma after pediatric congenital cataract surgery in the first 36 months of life[J]. Chinese Journal of Ophthalmology, 2013, 49(2): 134-138. doi:10.3760/cma.j.issn.0412-4081.2013.02.009 [22] 祁锦艳, 肖伟, 王明玥, 等. 婴幼儿先天性白内障吸除术后长期疗效观察[J]. 中华眼科杂志, 2017, 53(4): 266-273. doi:10.3760/cma.j.issn.0412-4081.2017.04.008 QI Jinyan, XIAO Wei, WANG Mingyue, et al. Long-term outcomes after cataract surgery in infants with congenital cataract[J]. Chinese Journal of Ophthalmology, 2017, 53(4): 266-273. doi:10.3760/cma.j.issn.0412-4081.2017.04.008 [23] Kruger SJ, Wilson ME, Hutchinson AK, et al. Cataracts and glaucoma in patients with oculocerebrorenal syndrome[J]. Arch Ophthalmol, 2003, 121(9): 1234-1237. doi: 10.1001/archopht.121.9.1234 |
[1] | 钟煜, 廖智敏,段宣初. XEN微支架在青光眼手术中的应用进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 145-151. |
[2] | 杨雪鹏,史陇,崔彦. 先天性白内障术后视网膜脱离合并睫状体环形纤维增生1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 51-55. |
[3] | 石博影,梁皓,李一洪,唐东永. Blau综合征成年患者抗青光眼手术后并发白内障手术治疗1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 60-65. |
[4] | 刘乐乐,孔香云综述申家泉审校. 睫状体分泌功能减弱性手术在青光眼治疗中的进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 123-128. |
[5] | 唐翡然,孔香云申家泉. 相干光层析血管成像术测量视盘旁浅层血管密度在青光眼诊疗中的作用研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 77-82. |
[6] | 赵颖,张珊许家骏,赵静如. 热休克蛋白72在青光眼视网膜神经节细胞中的保护机制研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 83-87. |
[7] | 李萱, 黄映湘. 25例虹膜新生血管发生原因探讨[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 41-47. |
[8] | 秦书琪,王露萍,姜彬,王艳玲. 眼缺血综合征并发新生血管性青光眼一例并文献复习[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 53-55. |
[9] | 刘瑞宝,赵颖,郭明璐,段钰,吴艳霞,路雪婧. 自噬及其在青光眼中的研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 158-161. |
[10] | 刘琳,郑华,谌绍林,段宣初. 干细胞移植对大鼠青光眼模型视神经保护作用及安全性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 138-144. |
[11] | 滕兴波,曹智,孙海霞,刘宪金,杨伟舟,朱艳,朱玉广. GRP94、EIF2α在原发型闭角性青光眼小梁中的作用研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 115-118. |
[12] | 陈莹,李元彬. 先天性白内障治疗新进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 143-148. |
[13] | 谢洪彬,杨美娜,陈青山,刘旭阳,樊宁. IgG4相关性眼病伴继发性青光眼病例分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 99-102. |
[14] | 高雪,郝琳琳,刘少华,张晗. 两种人工晶体计算公式预测闭角型青光眼合并白内障患者超声乳化手术后屈光度准确性的比较[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 68-71. |
[15] | 赵栋栋, 王艺, 高建鲁. 原发性开角型青光眼易感基因研究进展[J]. 山东大学耳鼻喉眼学报, 2017, 31(6): 92-96. |
|